Cargando…
THU248 Screening For Heart Failure In Patients With Diabetes Mellitus - A SwissDiab Study
Disclosure: M. Brandle: None. L. Knaus: None. M. Quarella: None. M. Maeder: None. M. Buser: None. F. Renstrom: None. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been shown to significantly reduce the risk of hospitalization for heart failure (HF) and death from cardiovascular causes in...
Autores principales: | Brandle, Michael, Knaus, Laura, Quarella, Marino, Maeder, Micha, Buser, Marc, Renstrom, Frida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554707/ http://dx.doi.org/10.1210/jendso/bvad114.685 |
Ejemplares similares
-
Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry
por: Schimke, Katrin E, et al.
Publicado: (2018) -
THU342 Per And Polyfluoroalkyl Substances And Prevalence Of Diabetes Mellitus In Korean Adults
por: Kim, Shin-Hye
Publicado: (2023) -
THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023) -
THU317 Study Of Risk Factors For The Development Of Various Subtypes Of Gestational Diabetes Mellitus
por: Volkova, Natalia I, et al.
Publicado: (2023) -
THU363 Misdiagnosing Latent Autoimmune Diabetes Mellitus In Adults: A Case Report
por: Rafat, Ummara, et al.
Publicado: (2023)